Tag Archives: Cancer

Common hypertension medications may reduce colorectal cancer risk

Research Highlights: People who take angiotensin converting enzyme inhibitors (ACE-i) or angiotensin II receptor blockers (ARBs) for conditions such as high blood pressure were less likely to be diagnosed with colorectal cancer after having a normal colonoscopy. This is the first study to show potential benefits on colorectal cancer development from these commonly prescribed hypertension… Read More »

Yoga Poses for Cancer Recovery

Yoga is a highly rated post-surgery cancer care technique. Every cancer survivor will choose to talk with their doctor about the best practices for their unique condition. As a trainer, your best shot lies in offering standard practices. In that case, have a credible tech company such as Gymcatch install a fitness instructor software to… Read More »

Using sponges to wipe out cancer

A sponge found in Manado Bay, Indonesia, makes a molecule called manzamine A, which stops the growth of cervical cancer cells, according to a recent publication in the Journal of Natural Products submitted by researchers at the Medical University of South Carolina (MUSC) and their collaborators. Collaborators include students and investigators at the University of… Read More »

‘I’m kind of scared’: Surgery for cancer patients and others cancelled as hospitals brace for possible COVID-19 wave

Janice Ense never actually got to talk to her doctor, or anyone else for that matter. While she was out on Monday, an assistant left Ense a voicemail message announcing that the unfolding COVID-19 crisis had forced the postponement of her kidney cancer surgery. The operation was supposed to take place next Thursday at Toronto’s… Read More »

Novel drug targets tumor growth in advanced kidney cancer

Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease. Researchers from Dana-Farber Cancer Institute report a response rate of 24 percent across all risk categories of patients given an oral first-in-class agent that targets hypoxia inducible factor (HIF) 2-a, which promotes… Read More »